Citation Information :
Kanala A, S, Prakasham PS. Invasive mediastinal Aspergillosis in immunocompetent male with invasion of left atrium and hilar structures. Indian J Crit Care Med 2017; 21 (6):408-411.
Aspergillus is described as mould characterised by septate hyphae about 2-4μ in diameter, it is ubiquitous in nature and spreads by inhalation of spores. It causes opportunistic infections in almost six forms namely Allergic bronchopulmonary aspergillosis, Aspergillus sinusitis, Cutaneous aspergillosis, Aspergilloma, Chronic pulmonary aspergillosis, Invasive aspergillosis. Invasive aspergillosis of mediastinum in an immunocompetent patient has rarely been reported. We present a case of a young male who had presented with chest pain, cough and breathleness was later diagnosed as fulminant mediastinal aspergillosis. Incisional biopsy with histology report and endotracheal cultures helped in diagnosing mediastinal aspergillosis. Despite initiation of the right antifungal therapy and best supportive measures, patient died of septic shock and multiorgan dysfunction. This case report highlights the need for higher suspicion in such cases of mediastinal masses and early tissue biopsy which can help in reducing mortality.
Choyke PL, Edmonds PR, Markowitz RI, Kleinman CS, Laks H. Mycotic pulmonary artery aneurysm: Complication of Aspergillus endocarditis. AJR Am J Roentgenol 1982;138:1172-5.
Kirshenbaum JM, Lorell BH, Schoen FJ, Bettmann MA, Thompson GB. Angioinvasive pulmonary aspergillosis: Presentation as massive pulmonary saddle embolism in an immunocompromised patient. J Am Coll Cardiol 1985;6:486-9.
Shakoor MT, Ayub S, Ayub Z, Mahmood F. Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: A case report. J Med Case Rep 2012;6:311.
Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002;121:1988-99.
Dar MA, Ahmad M, Weinstein AJ, Mehta AC, Golish JA. Thoracic aspergillosis (part I). Overview and aspergilloma. Cleve Clin Q 1984;51:615-30.
Mehta AC, Dar MA, Ahmad M, Weinstein AJ, Golish JA. Thoracic aspergillosis (part III). Invasive pulmonary and disseminated aspergillosis. Cleve Clin Q 1984;51:655-65.
Rubio PA, Nelson PW. Mycotic thoracic aortic aneurysm producing vertebral body destruction and paraplegia: Case report. Paraplegia 1989;27:406-9.
Munta K, Gopal PB, Vigg A. Invasive aspergillosis in near drowning nonneutropenic patient. Indian J Crit Care Med 2015;19:739-42.
Walsh TJ. Invasive pulmonary aspergillosis in patients with neoplastic diseases. Semin Respir Infect 1990;5:111-22.
Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-57.
Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin Infect Dis 2006;42:1417-27.
Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002;186:1297-306.
Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000;79:250-60.
Mullen P, Jude C, Borkon M, Porterfield J, Walsh TJ. Aspergillus mural endocarditis. Clinical and echocardiographic diagnosis. Chest 1986;90:451-2.